Pardes Biosciences, Inc. – NASDAQ:PRDS
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
Pardes Biosciences stock price monthly change
+16.13%
month
Pardes Biosciences stock price quarterly change
+13.68%
quarter
Pardes Biosciences stock price yearly change
-38.81%
year
Pardes Biosciences key metrics
Market Cap | 135.18M |
Enterprise value | N/A |
P/E | -0.85 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 0.49 |
PEG ratio | 2.32 |
EPS | -1.63 |
Revenue | N/A |
EBITDA | -82.88M |
Income | -96.28M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePardes Biosciences stock price history
Pardes Biosciences stock forecast
Pardes Biosciences financial statements
| Sep 2022 | 0 | -21.41M | |
|---|---|---|---|
| Dec 2022 | 0 | -49.91M | |
| Mar 2023 | 0 | -14.17M | |
| Jun 2023 | 0 | -10.77M |
| Sep 2022 | 214041000 | 12.02M | 5.62% |
|---|---|---|---|
| Dec 2022 | 200621000 | 20.42M | 10.18% |
| Mar 2023 | 176145000 | 11.41M | 6.48% |
| Jun 2023 | 157310000 | 1.92M | 1.22% |
| Sep 2022 | -19.54M | 0 | 0 |
|---|---|---|---|
| Dec 2022 | -12.75M | -137 | 396.86K |
| Mar 2023 | -26.53M | 14.41M | 0 |
| Jun 2023 | -19.91M | 73.01M | 0 |
Pardes Biosciences alternative data
| Aug 2023 | 57 |
|---|---|
| Sep 2023 | 57 |
| Oct 2023 | 57 |
| Nov 2023 | 57 |
| Dec 2023 | 57 |
| Jan 2024 | 57 |
| Feb 2024 | 57 |
| Mar 2024 | 57 |
| Apr 2024 | 57 |
| May 2024 | 57 |
| Jun 2024 | 57 |
| Jul 2024 | 57 |
Pardes Biosciences other data
33.10%
-31.59%
of PRDS is owned by hedge funds
33
-30
19.23M
-18.52M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2022 | 708420 | 0 |
| Apr 2023 | 1547904 | 0 |
-
When is Pardes Biosciences's next earnings date?
Unfortunately, Pardes Biosciences's (PRDS) next earnings date is currently unknown.
-
Does Pardes Biosciences pay dividends?
No, Pardes Biosciences does not pay dividends.
-
How much money does Pardes Biosciences make?
Pardes Biosciences has a market capitalization of 135.18M.
-
What is Pardes Biosciences's stock symbol?
Pardes Biosciences, Inc. is traded on the NASDAQ under the ticker symbol "PRDS".
-
What is Pardes Biosciences's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Pardes Biosciences?
Shares of Pardes Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Pardes Biosciences have?
As Jul 2024, Pardes Biosciences employs 57 workers.
-
When Pardes Biosciences went public?
Pardes Biosciences, Inc. is publicly traded company for more then 3 years since IPO on 27 Dec 2021.
-
What is Pardes Biosciences's official website?
The official website for Pardes Biosciences is pardesbio.com.
-
Where are Pardes Biosciences's headquarters?
Pardes Biosciences is headquartered at 2173 Salk Avenue, Carlsbad, CA.
-
How can i contact Pardes Biosciences?
Pardes Biosciences's mailing address is 2173 Salk Avenue, Carlsbad, CA and company can be reached via phone at +41 56498758.
Pardes Biosciences company profile:
Pardes Biosciences, Inc.
pardesbio.comExchange:
NASDAQ
Full time employees:
57
Industry:
Biotechnology
Sector:
Healthcare
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.
2173 Salk Avenue
Carlsbad, CA 92008
Carlsbad, CA 92008
CIK: 0001822711
ISIN: US69945Q1058
CUSIP: 69945Q105
